Difficulty: Medium
Average Score: 85%
Practice
Following agent potentiates actions of GABA
Correct answer
D
Rationale
In the context of CNS pharmacology, the correct answer to the question is option D: All of the above. This is because volatile anesthetics, barbiturates, and propofol all potentiate the actions of GABA (gamma-aminobutyric acid), the main inhibitory neurotransmitter in the central nervous system.
Volatile anesthetics such as isoflurane and desflurane enhance GABAergic transmission by interacting with GABA-A receptors, leading to increased inhibitory effects in the CNS. Barbiturates like phenobarbital also act on GABA-A receptors, potentiating GABA's inhibitory actions, which results in sedative and hypnotic effects. Propofol, a commonly used intravenous anesthetic, enhances GABAergic neurotransmission by increasing the duration of GABA-A receptor channel opening, leading to CNS depression and anesthesia.
Option A (Volatile anesthetics), Option B (Barbiturates), and Option C (Propofol) are incorrect because each of them, individually, potentiates the actions of GABA in the CNS. Understanding how different pharmacological agents interact with GABA receptors is crucial for healthcare professionals involved in anesthesia, neurology, psychiatry, and pharmacology.
By grasping the mechanisms through which these drugs enhance GABAergic transmission, healthcare providers can make informed decisions about drug selection, dosing, and potential drug interactions, ultimately ensuring safe and effective patient care in various clinical settings.
Volatile anesthetics such as isoflurane and desflurane enhance GABAergic transmission by interacting with GABA-A receptors, leading to increased inhibitory effects in the CNS. Barbiturates like phenobarbital also act on GABA-A receptors, potentiating GABA's inhibitory actions, which results in sedative and hypnotic effects. Propofol, a commonly used intravenous anesthetic, enhances GABAergic neurotransmission by increasing the duration of GABA-A receptor channel opening, leading to CNS depression and anesthesia.
Option A (Volatile anesthetics), Option B (Barbiturates), and Option C (Propofol) are incorrect because each of them, individually, potentiates the actions of GABA in the CNS. Understanding how different pharmacological agents interact with GABA receptors is crucial for healthcare professionals involved in anesthesia, neurology, psychiatry, and pharmacology.
By grasping the mechanisms through which these drugs enhance GABAergic transmission, healthcare providers can make informed decisions about drug selection, dosing, and potential drug interactions, ultimately ensuring safe and effective patient care in various clinical settings.